[HTML][HTML] Systematic review update and meta-analysis of randomized and non-randomized controlled trials of ovarian stimulation versus artificial cycle for endometrial …

Y Zhang, L Wu, TC Li, CC Wang, T Zhang… - Reproductive Biology …, 2022 - Springer
Purpose This systematic review and meta-analysis aimed to compare the short-term
reproductive and long-term obstetric outcomes after endometrial preparations by ovarian …

[HTML][HTML] Women with PCOS who undergo IVF: a comprehensive review of therapeutic strategies for successful outcomes

AM Kotlyar, DB Seifer - Reproductive Biology and Endocrinology, 2023 - Springer
Polycystic ovarian syndrome (PCOS) is a widespread syndrome that poses unique
challenges and constraints to the field of assisted reproductive technology. This condition is …

[HTML][HTML] PCOS in Adolescents—Ongoing riddles in diagnosis and treatment

B Meczekalski, O Niwczyk, A Kostrzak… - Journal of Clinical …, 2023 - mdpi.com
Polycystic ovary syndrome (PCOS) is one of the most common endocrine disorders in
women of reproductive age. A diagnosis of PCOS is established when a patient exhibits two …

[HTML][HTML] Cannabinoids and PPAR ligands: the future in treatment of polycystic ovary syndrome women with obesity and reduced fertility

P Przybycień, D Gąsior-Perczak, W Placha - Cells, 2022 - mdpi.com
Cannabinoids (CBs) are used to treat chronic pain, chemotherapy-induced nausea and
vomiting, and multiple sclerosis spasticity. Recently, the medicinal use of CBs has attracted …

[HTML][HTML] Prevalence of polycystic ovary syndrome in patients with type 2 diabetes: A systematic review and meta-analysis

C Long, H Feng, W Duan, X Chen, Y Zhao… - Frontiers in …, 2022 - frontiersin.org
Purpose With type 2 diabetes mellitus (T2DM) occurring at a younger age, a greater number
of women with T2DM experience reproductive health problems. The prevalence of polycystic …

[HTML][HTML] A review of the hormones involved in the endocrine dysfunctions of polycystic ovary syndrome and their interactions

RHK Emanuel, J Roberts, PD Docherty… - Frontiers in …, 2022 - frontiersin.org
Polycystic ovary syndrome (PCOS) affects up to 20% of women but remains poorly
understood. It is a heterogeneous condition with many potential comorbidities. This review …

[HTML][HTML] Canagliflozin combined with metformin versus metformin monotherapy for endocrine and metabolic profiles in overweight and obese women with polycystic …

J Zhang, C Xing, X Cheng, B He - Frontiers in Endocrinology, 2022 - frontiersin.org
Objectives Canagliflozin (CANA), a kind of sodium-glucose cotransporter-2 (SGLT-2)
inhibition, study in which the role of CANA monotherapy in polycystic ovary syndrome …

[HTML][HTML] Astaxanthin treatment ameliorates ER stress in polycystic ovary syndrome patients: A randomized clinical trial

M Jabarpour, A Aleyasin, MS Nashtaei, S Lotfi… - Scientific Reports, 2023 - nature.com
Astaxanthin (ASX), as a natural carotenoid compound, exists in various types of seafood and
microorganisms. It has several possible beneficial therapeutic effects for patients with …

[HTML][HTML] Intrauterine perfusion of autologous platelet-rich plasma before frozen-thawed embryo transfer improves the clinical pregnancy rate of women with recurrent …

Y Xu, C Hao, J Fang, X Liu, P Xue, R Miao - Frontiers in Medicine, 2022 - frontiersin.org
Objective: To evaluate whether the intrauterine perfusion of platelet-rich plasma (PRP)
before frozen-thawed embryo transfer (FET) improves the pregnancy outcomes of patients …

[HTML][HTML] The mutational analysis of mitochondrial DNA in maternal inheritance of polycystic ovarian syndrome

S Bibi, G Abbas, MZ Khan, T Nawaz, Q Ullah… - Frontiers in …, 2023 - frontiersin.org
Introduction Polycystic Ovarian Syndrome (PCOS) is a globally prevalent condition that
leads to infertility in women. While environmental factors contribute to PCOS, maternal …